Medical

Medical vs. Recreational Cannabis: Which Is the Future?

Both cannabis markets are drawing attention. How are these two companies approaching these segments?

The potential of medical marijuana is widely known, not only in Canada and the U.S., but also globally. Many patients find that medical cannabis has helped them with certain health issues where conventional medicine has failed, including chronic pain, post-traumatic stress disorder (PTSD), Crohn's disease, and anxiety.

White paper aims to accelerate cannabis integration into UK healthcare

A new white paper has been published by leaders in the cannabis field, showcasing how to maximise clinical research and improve patient access to medical cannabis in the UK.

Following the approval of medical cannabis in the UK in November 2018, only two patients have gained access to full extract cannabis medicine through an NHS prescription.

Researchers Are Looking At Cannabis As A Potential Way To Prevent COVID-19

Two Canadian researchers think that a special strain of cannabis might potentially be a valuable tool in the fight against COVID-19.

The researchers, Olga and Igor Kovalchuck have reportedly been developing and testing a novel cannabis strain for years, except with the goal of creating a strain that helps to combat cancer and inflammation. When the pandemic hit, the duo started to focus their efforts on how the strain might be used to help fight COVID-19.

Marijuana advocates race to qualify for the ballot

The pandemic forced some legalization campaigns to fold, but others are still fighting to make it before voters in November.

The coronavirus pandemic may have upended marijuana advocates’ plans for a banner year of legalization ballot initiatives. But advocates in a handful of states are still fighting to salvage campaigns to put legalization questions to voters in November.

Could the UK Learn from the German Medical Cannabis Model?

In recent years, global medical cannabis markets have continued to expand as research and public opinion of the plant has evolved. Now, much of Europe has at least partially legalised cannabis for medical use. But there is one European country that has seen the lion’s share of investment in the sector, thanks to its progressive medical cannabis model – Germany. 

An “Essential” Distinction? Medical Versus Recreational Marijuana In The Time Of COVID-19

When Mitt Romney was running for president in 2012, he traveled to Colorado, where a reporter questioned him about the state’s impending legalization of recreational marijuana.

“Ask me about something important,” he shot back, before calling on the next journalist. 

Louisiana widening access to medical marijuana under new law

More Louisiana residents will have access to medical marijuana under a significant expansion of the state’s therapeutic cannabis program that Gov. John Bel Edwards has signed into law

More Louisiana residents will have access to medical marijuana under a significant expansion of the state's therapeutic cannabis program that was signed into law by Gov. John Bel Edwards.

Drug Trial Planned for Synthetic Cannabinoid COVID-19 Treatment

FSD Pharma has received FDA permission to design and submit an application for a new trial using a synthetic cannabinoid-based drug in the treatment of COVID-19.

Philadelphia, Pennsylvania-based cannabis company FSD Pharma has been granted permission by the Food and Drug Administration to submit an Investigational New Drug Application for a clinical trial using a synthetic cannabinoid drug called ultramicronized palmitoylethanolamide (micro PEA) to treat COVID-19.